SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-03-001804
Filing Date
2003-08-07
Accepted
2003-08-06 20:09:26
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g_080603-capital.txt SC 13G 7529
3 JOINT FILING AGREEMENT ex1-1_080603capital.txt EX-1.1 1955
4 STATEMENT OF CONTROL PERSON ex2-1_080603capital.txt EX-2.1 737
  Complete submission text file 0000947871-03-001804.txt   12573
Mailing Address 600 COLLEGE RD EAST CN 5308 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540
Business Address 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Subject) CIK: 0000725058 (see all company filings)

IRS No.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37931 | Film No.: 03827485
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 2127396400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231